Eva
Bandres Elizalde
Forscherin bis um 2004
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von University of Texas MD Anderson Cancer Center (2)
2021
-
Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET
Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820
2011
-
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas
PLoS ONE, Vol. 6, Núm. 10